The Future of the Quinolones
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 58 (2) , 1-5
- https://doi.org/10.2165/00003495-199958002-00001
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Activities of New Fluoroquinolones against Fluoroquinolone-Resistant Pathogens of the Lower Respiratory TractAntimicrobial Agents and Chemotherapy, 1998
- Fluoroquinolone Action against Mycobacteria: Effects of C-8 Substituents on Growth, Survival, and ResistanceAntimicrobial Agents and Chemotherapy, 1998
- In vitro activity of quinupristin/dalfopristin and newer quinolones combined with gentamicin against resistant isolates of Enterococcus faecalis and Enterococcus faecium.European Journal of Clinical Microbiology & Infectious Diseases, 1998
- Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1995
- Improved bactericidal activity of Q-35 against quinolone-resistant staphylococciAntimicrobial Agents and Chemotherapy, 1995
- Structure-activity and structure-side-effect relationships for the quinolone antibacterialsJournal of Antimicrobial Chemotherapy, 1994
- Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examplesAntimicrobial Agents and Chemotherapy, 1993
- Pharmacokinetics of three newer quinolones in pregnant and lactating womenThe American Journal of Medicine, 1989
- Nalidixic acid resistance: A second genetic character involved in DNA gyrase activityProceedings of the National Academy of Sciences, 1977
- Nalidixic acid and bacterial chromosome replicationNature, 1976